BioCentury
ARTICLE | Strategy

Program in orbit

Cancer Moonshot turbocharges drug combination research

September 22, 2016 7:00 AM UTC

Since the Cancer Moonshot was kicked off in February amid much fanfare, one of the main questions to emerge has been what the initiative will achieve that wouldn't have been done in all events. Though many of the programs offer little evidence of breaking new ground, a standout is the NCI's Drug Formulary - a compound-sharing system to grow combination therapy research by an order of magnitude that could make better treatments reach patients sooner.

This month, the Moonshot's Blue Ribbon Panel provided the next phase of details on how the initiative plans to put $1 billion to work doubling the pace of cancer discovery, rounding out the information provided in June by the Cancer Moonshot Task Force...